Delivering Therapeutics to Residual Active HIV Reservoirs (R01)

The summary for the Delivering Therapeutics to Residual Active HIV Reservoirs (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Delivering Therapeutics to Residual Active HIV Reservoirs (R01): The purpose of this FOA is to solicit new ideas for eliminating cellular reservoirs of HIV that continue to actively produce virus in tissue compartments despite suppression of plasma viremia with antiretroviral therapy. New approaches to delivering antiretrovirals or other anti-HIV agents to these tissues or to specific cell types are needed to block virus production and infection, limit inflammation, and facilitate clearance of these reservoir cells.
Federal Grant Title: Delivering Therapeutics to Residual Active HIV Reservoirs (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-12-042
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: Jul 24, 2013
Original Application Deadline: Jul 24, 2013
Posted Date: Jan 15, 2013
Creation Date: Jan 15, 2013
Archive Date: Aug 24, 2013
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of...
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of...
Multimodal Artificial Intelligence to Accelerate HIV Clinical Care (R01 Clinical Trial Opt...
Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health D...
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Acces...
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed...
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiate...
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiate...
National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2025 FederalGrants.com